| Market Cap | ₹17,585.75 CrMid Cap |
|---|---|
| Revenue TTM | ₹1,153.48 CrOperating Revenue |
| PE Ratio | 80.13Trailing 12 Months |
| Day RSI | 72.59Overbought Zone |
Key highlights
- Commercial operations began on June 26, 2026, at Manufacturing Site 5 in Panoli, Gujarat
- Initial production phase includes two fully operational blocks at Plot No. 14+15
- Expansion is expected to be a primary contributor to extended production volumes
- Aether reported an annual operating revenue growth of 34.16% prior to this launch
- The site aligns with the company's strategy for sustained revenue growth in coming years
Production Commenced — What It Means
Aether Industries has successfully initiated commercial operations at its Manufacturing Site 5, situated at Plot No. 14+15 in GIDC Panoli, Gujarat. This milestone involves the activation of two specific blocks under the project's first phase.
By expanding its physical infrastructure in the Panoli industrial belt, the company is scaling its ability to deliver complex specialty chemicals. The activation of these production units follows a period of targeted capital expenditure aimed at broadening the company’s manufacturing base, which is crucial for meeting rising demand from global pharmaceutical and agrochemical clients who require scalable production partners.
Revenue Impact and Capacity Expansion
The operationalization of Site 5 is projected to act as a primary catalyst for future revenue acceleration. Aether Industries reported a trailing twelve-month net profit of ₹219.46 crore and an annual revenue growth rate of 34.16% for the previous fiscal. The addition of new capacity through the first phase of Site 5 allows the company to transition from its previous production constraints toward a higher volume output model.
This expansion is designed to improve economies of scale and support the company's profitability profile, which recently featured an operating profit margin of 27.1% at the quarterly level.
Business Overview
- Specializes in the manufacture of advanced intermediates and active ingredients for global markets
- Operates a research-led business model integrating R&D with large-scale manufacturing
- Provides Contract Research and Manufacturing Services (CRAMS) to diversified sectors
- Maintains a high durability score of 55 according to recent financial performance metrics
- Serves critical industries including pharmaceuticals, agrochemicals, and material sciences
Sector Tailwinds
The Indian specialty chemicals industry is currently benefiting from global supply chain realignments. Domestic manufacturers like Aether are witnessing increased inquiries as international firms seek reliable alternative sourcing partners for critical intermediates. Furthermore, the Indian chemical sector is projected to grow significantly due to rising domestic consumption and increased export competitiveness.
Favorable infrastructure in industrial hubs like GIDC Panoli provides the necessary environment for companies to scale operations rapidly, allowing them to capture a larger share of the global chemical market while leveraging local manufacturing efficiencies.
“The said manufacturing site is expected to be a key contributor towards achieving the Company’s extended production capacities and revenue growth going forward in the coming years.”
| Share price | ₹1325.1 |
|---|---|
| Market capitalisation | ₹17,585.75 Cr |
| Revenue (annual) | ₹1,160.14 Cr |
| Net profit (annual) | ₹219.46 Cr |
| Revenue (latest quarter) | ₹305.12 Cr-3.78% vs previous quarter |
| Net profit (latest quarter) | ₹54.01 Cr-16.24% vs previous quarter |
| P/E (TTM) | 80.13×Sector 43.91× |
| Promoter holding | 74.95%-0.03% QoQ |
| FII holding | 6.29%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Aether Industries Limited announcing the commencement of commercial operations at Manufacturing Site 5. Market figures from a third-party data provider.
